DRAVET SYNDROME (DS)
Clinical trials for DRAVET SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety testing for promising epilepsy drug in children
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called soticlestat when added to existing seizure medications. It involved 156 children and young adults with severe, hard-to-treat forms of epilepsy, including Dravet and Lennox-Gastaut syndromes. Participant…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Extended trial tests Add-On drug for severe childhood seizure disorders
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called soticlestat when taken alongside standard medications. It involved about 352 children and adults with Dravet Syndrome or Lennox-Gastaut Syndrome, two rare and severe forms of epilepsy. The main goal was…
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC